These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6549027)

  • 1. Evaluation of endocrine ophthalmopathy with saccadic eye movements.
    Mauri L; Meienberg O; Roth E; König MP
    J Neurol; 1984; 231(4):182-7. PubMed ID: 6549027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional eye muscle changes in endocrine orbitopathy].
    Schworm HD; Heufelder AE; Bötzel K; Leikam B; Beicht L; Boergen KP
    Ophthalmologe; 1997 Apr; 94(4):290-4. PubMed ID: 9229499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measuring saccades in endocrine orbitopathy].
    Schworm HD; Buser A; Bötzel K; Heufelder AE; Leikam B; Boergen KP
    Ophthalmologe; 1997 Mar; 94(3):211-6. PubMed ID: 9181838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eye muscle force development and saccadic velocity in thyroid-associated ophthalmopathy.
    Tian S; Lennerstrand G; Nishida Y; Tallstedt L
    Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):740-6. PubMed ID: 12827376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latency of horizontal saccadic eye movements in thyrotoxicosis.
    Neumann E; Pollak A; Friedman Z; Zeevi YY
    Metab Pediatr Ophthalmol; 1981; 5(2):111-5. PubMed ID: 7289685
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes of saccadic eye movements in thyroid-associated ophthalmopathy.
    Schworm HD; Bolzani R; Benassi M; Tallstedt L; Rydberg A; Lennerstrand G; Ygge J
    Acta Ophthalmol; 2012 Dec; 90(8):713-20. PubMed ID: 21801340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' ophthalmopathy. Correlation of saccadic eye movements with age, presence of optic neuropathy, and extraocular muscle volume.
    Feldon SE; Levin L; Liu SK
    Arch Ophthalmol; 1990 Nov; 108(11):1568-71. PubMed ID: 2244842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of saccade analysis in early active Graves' ophthalmopathy.
    Schworm HD; Heufelder AE; Kunze A; Welge E; Boergen KP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1710-8. PubMed ID: 10845590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motility disturbances in Graves' ophthalmopathy.
    de Waard R; Koornneef L; Verbeeten B
    Doc Ophthalmol; 1983 Dec; 56(1-2):41-7. PubMed ID: 6689301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronology of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccadic eye movement velocity measured with the infrared reflection and search coil eye-tracking systems in patients with thyroid-associated ophthalmopathy.
    Träisk F; Bolzani R; Tallstedt L; Schworm HD; Ygge J
    Strabismus; 2007; 15(4):173-80. PubMed ID: 18058353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of ocular saccadic movements with a fatigue test and neostigmine in Graves' ophthalmopathy].
    di Lorenzo L; Savastano S; Di Costanzo A; Scarpitta MT; Gigante M; Dorato M
    Minerva Endocrinol; 1997 Mar; 22(1):7-12. PubMed ID: 9221313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological criteria of isolated Graves' ophthalmopathy].
    Laferrère B; Madec AM; Orgiazzi J; Mornex R
    Presse Med; 1987 Apr; 16(15):711-4. PubMed ID: 2953009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of small saccadic eye movements in endocrine myopathies].
    Brovkina AF; Tiutiunnikova AM; Naumova TP
    Vestn Oftalmol; 1984; (1):44-7. PubMed ID: 6710744
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary report: saccade analysis in acute Graves' ophthalmopathy.
    Schworm HD; Boergen KP
    Strabismus; 2000 Sep; 8(3):179-85. PubMed ID: 11035560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye muscle force development in thyroid-associated ophthalmopathy in different stages of disease.
    Tian S; Bolzani R; Benassi M; Lennerstrand G
    Acta Ophthalmol Scand; 2007 Jun; 85(4):431-7. PubMed ID: 17559468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscle antigens recognized with autoantibodies in patients with Graves' ophthalmopathy].
    Adler G
    Endokrynol Pol; 1992; 43(1 Suppl):1-61. PubMed ID: 1345558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early diagnosis of endocrine ophthalmopathy using eye movement tonometry].
    Klima G; Friess HG; Hesse W; Eber O
    Acta Med Austriaca; 1986; 13(1):9-11. PubMed ID: 3766085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' ophthalmopathy evaluated by infrared eye-movement recordings.
    Feldon SE; Unsöld R
    Arch Ophthalmol; 1982 Feb; 100(2):324-8. PubMed ID: 6895994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.